How good enough are the new therapies for lupus nephritis? A narrative review and a position paper
- 7 November 2025
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (2) , 227-234
Abstract
No abstract availableKeywords
Funding Information
- Cliniques Universitaires Saint-Luc
This publication has 61 references indexed in Scilit:
- Effect of long‐term voclosporin treatment on renal histology in patients with active lupus nephritis with repeat renal biopsiesArthritis & Rheumatology, 2025
- Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment ResponseArthritis & Rheumatology, 2024
- Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta‐Analysis of the Control Arms of Randomized Controlled TrialsArthritis & Rheumatology, 2024
- Urine Proteomics and Renal Single‐Cell Transcriptomics Implicate Interleukin‐16 in Lupus NephritisArthritis & Rheumatology, 2022
- Brief Report: Lupus—An Unrecognized Leading Cause of Death in Young Females: A Population‐Based Study Using Nationwide Death Certificates, 2000–2015Arthritis & Rheumatology, 2018
- Brief Report: The Euro‐Lupus Low‐Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti–Müllerian HormoneArthritis & Rheumatology, 2017
- Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis CohortArthritis & Rheumatology, 2015
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab studyArthritis & Rheumatism, 2012
- Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis TrialArthritis & Rheumatism, 2004
- Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamideArthritis & Rheumatism, 2002